Enanta Pharmaceuticals
ENTA
#8126
Rank
C$0.51 B
Marketcap
C$17.82
Share price
3.31%
Change (1 day)
11.04%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2026 : C$0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has C$0.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-09-30$C$90.1 M-48.29%
2024-09-30$C$0.17 B-40.84%
2023-09-30$C$0.29 B-33.47%
2022-09-30$C$0.44 B-12.61%
2021-09-30$C$0.50 B-16.42%
2020-09-30$C$0.60 B-1.02%
2019-09-30$C$0.61 B21.15%
2018-09-30$C$0.50 B35.08%
2017-09-30$C$0.37 B5.32%
2016-09-30$C$0.35 B12.98%
2015-09-30$C$0.31 B88.79%
2014-09-30$C$0.16 B46.07%
2013-09-30$C$0.11 B163.78%
2012-09-30$C$43.23 M89.98%
2011-09-30$C$22.75 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$121.11 B 83,973.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$59.78 B 41,402.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
-C$8.4 Billion-5,925.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$28.86 B 19,933.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$59.84 B 41,440.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$31.81 B 21,983.15%๐Ÿ‡บ๐Ÿ‡ธ USA